Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 727,900 | 4,684,800 | 3,957,300 | 2,754,200 | 1,548,000 |
| Depreciation Amortization | 348,800 | 1,445,600 | 1,094,400 | 745,400 | 381,500 |
| Income taxes - deferred | 70,000 | 265,900 | 807,600 | 198,900 | -51,000 |
| Accounts receivable | N/A | -152,700 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -70,300 | N/A | N/A | N/A |
| Other Working Capital | -917,800 | -393,000 | -1,498,300 | -1,271,500 | -1,048,100 |
| Other Operating Activity | 43,400 | -45,300 | -352,800 | -410,400 | -451,000 |
| Operating Cash Flow | $272,300 | $5,735,000 | $4,008,200 | $2,016,600 | $379,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 764,100 | 1,789,100 | 1,599,500 | 1,466,300 | 1,294,400 |
| PPE Investments | -202,000 | -832,700 | -548,100 | -294,300 | -157,900 |
| Net Acquisitions | N/A | -43,700 | -43,700 | N/A | N/A |
| Purchase Of Investment | -2,770,200 | -14,041,900 | -10,239,500 | -6,476,100 | -1,861,400 |
| Sale Of Investment | 2,633,400 | 11,235,000 | 8,482,900 | 5,463,200 | 2,098,400 |
| Purchase Sale Intangibles | N/A | -24,100 | 0 | 0 | 0 |
| Other Investing Activity | -36,900 | -178,600 | -91,500 | -55,700 | -18,400 |
| Investing Cash Flow | $388,400 | $-2,072,800 | $-840,400 | $103,400 | $1,355,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -9,100 | N/A | -3,000 | -1,700 | -900 |
| Debt Repayment | N/A | -10,500 | N/A | N/A | N/A |
| Common Stock Repurchased | -55,000 | -1,698,100 | -1,198,100 | -1,198,100 | -1,198,100 |
| Dividend Paid | -524,100 | -2,120,700 | -1,591,800 | -1,064,100 | -531,100 |
| Other Financing Activity | -6,900 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-595,100 | $-3,829,300 | $-2,792,900 | $-2,263,900 | $-1,730,100 |
| Exchange Rate Effect | -7,800 | -21,500 | -24,800 | -88,400 | -86,600 |
| Beginning Cash Position | 3,830,200 | 4,018,800 | 4,018,800 | 4,018,800 | 4,018,800 |
| End Cash Position | 3,888,000 | 3,830,200 | 4,368,900 | 3,786,500 | 3,936,600 |
| Net Cash Flow | $57,800 | $-188,600 | $350,100 | $-232,300 | $-82,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 272,300 | 5,735,000 | 4,008,200 | 2,016,600 | 379,400 |
| Capital Expenditure | -202,000 | -1,012,100 | -548,100 | -294,300 | -157,900 |
| Free Cash Flow | 70,300 | 4,722,900 | 3,460,100 | 1,722,300 | 221,500 |